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Background: Whole-body vibration is commonly used in physical medicine and
neuro-rehabilitation as a clinical prevention and rehabilitation tool. The goal of this
systematic review is to assess the long-term effects of whole-body vibration training on
gait in different populations of patients.
Methods: We conducted a literature search in PubMed, Science Direct, Springer, Sage
and in study references for articles published prior to 7 December 2018. We used
the keywords “vibration,” “gait” and “walk” in combination with their Medical Subject
Headings (MeSH) terms. The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) methodology was used. Only randomized controlled trials
(RCT) published in English peer-reviewed journals were included. All patient categories
were selected. The duration of Whole-Body Vibration (WBV) training had to be at least
4 weeks. The outcomes accepted could be clinical or biomechanical analysis. The
selection procedure was conducted by two rehabilitation experts and disagreements
were resolved by a third expert. Descriptive data regarding subjects, interventions, types
of vibration, training parameters and main results on gait variables were collected and
summarized in a descriptive table. The quality of selected studies was assessed using the
PEDro scale. Statistical analysis was conducted to evaluate intergroup differences and
changes after the WBV intervention compared to the pre-intervention status. The level of
evidence was determined based on the results of meta-analysis (effect size), statistical
heterogeneity (I2) and methodological quality (PEDro scale).
Results: A total of 859 studies were initially identified through databases with 46
articles meeting all of the inclusion criteria and thus selected for qualitative assessment.
Twenty-five studies were included in meta-analysis for quantitative synthesis. In elderly
subjects, small but significant improvements in the TUG test (SMD = −0.18; 95% CI:
−0.32,−0.04) and the 10MWT (SMD=−0.28; 95%CI:−0.56,−0.01) were found in the
WBV groups with a strong level of evidence (I2 = 7%, p = 0.38 and I2 = 22%, p = 0.28,
respectively; PEDro scores ≥5/10). However, WBV failed to improve the 6MWT (SMD =
0.37; 95%CI:−0.03, 0.78) and the Tinetti gait scores (SMD= 0.04; 95%CI:−0.23, 0.31)
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in older adults. In stroke patients, significant improvement in the 6MWT (SMD = 0.33;
95% CI: 0.06, 0.59) was found after WBV interventions, with a strong level of evidence
(I2 = 0%, p = 0.58; PEDro score ≥5/10). On the other hand, there was no significant
change in the TUG test despite a tendency toward improvement (SMD=−0.29; 95% CI:
−0.60, 0.01). Results were inconsistent in COPD patients (I2 = 66%, p = 0.03), leading
to a conflicting level of evidence despite a significant improvement with a large effect size
(SMD = 0.92; 95% CI: 0.32, 1.51) after WBV treatment. Similarly, the heterogeneous
results in the TUG test (I2 = 97%, p < 0.00001) in patients with knee osteoarthrosis
make it impossible to draw a conclusion. Still, adding WBV treatment was effective in
significantly improving the 6 MWT (SMD = 1.28; 95% CI: 0.57, 1.99), with a strong level
of evidence (I2 = 64%, p= 0.06; PEDro score≥5/10). As in stroke, WBV failed to improve
the results of the TUG test in multiple sclerosis patients (SMD = −0.11; 95% CI: −0.64,
0.43). Other outcomes presented moderate or even limited levels of evidence due to the
lack of data in some studies or because only one RCT was identified in the review.
Conclusions: WBV training can be effective for improving balance and gait speed in
the elderly. The intervention is also effective in improving walking performance following
stroke and in patients with knee osteoarthrosis. However, no effect was found on gait
quality in the elderly or on balance in stroke andmultiple sclerosis patients. The results are
too heterogenous in COPD to conclude on the effect of the treatment. The results must
be taken with caution due to the lack of data in some studies and the methodological
heterogeneity in the interventions. Further research is needed to explore the possibility of
establishing a standardized protocol targeting gait ability in a wide range of populations.
Keywords: whole-body vibration, long-term effects, gait, biomechanics, randomized controlled trials, meta-
analysis
HIGHLIGHTS
- WBV is currently used in locomotor rehabilitation.
- WBV presents strong evidence for improving performance in
the timed-up-and-go test in the elderly, but not in stroke or
multiple sclerosis patients.
- WBV presents strong evidence for improving performance in
the 10-meter walk test for elderly, in the 6-min walk test for
stroke and knee OA patients but results are conflicting in
COPD patients.
- Other outcomes present moderate or limited levels of evidence
due to the lack of data or because only one RCT was identified
in other pathologies.
INTRODUCTION
Whole-body vibration (WBV) is a therapeutic method that
exposes the entire body to mechanical oscillations while the
patient stands or sits on a vibrating platform. This method was
first used in the late nineteenth century by Charcot to treat
gait disorders in neurological patients, especially in patients
with Parkinson’s disease (1). It is now commonly used in the
physical medicine/neuro-rehabilitation fields as a prevention and
rehabilitation tool for sarcopenia (2), osteoporosis (3), chronic
low back pain (4), and fibromyalgia (5), among other conditions.
WBV is also used in rehabilitation to improve muscle function
(strength, power, and endurance) (6), muscle soreness (7), joint
stability (8) and to reduce the risk of falling (9).
Several spinal and supraspinal mechanisms have been
proposed to explain increased muscle activity during exposure to
WBV.While there is currently no consensus, the most frequently
cited mechanism is a reflex muscular contraction called tonic
vibration reflex (TVR). This phenomenon has been shown to
occur during direct and indirect vibratory musculo-tendinous
stimulations that excite muscle spindles and enhance activation
of Ia afferents, resulting in a higher recruitment of motor units
and gradual development of muscle activity (10). In addition to
these spinal reflexes, neuromuscular changes (11, 12), increased
intramuscular temperature (10) and peripheral blood flow (13)
may contribute at different levels to the increased muscular
performance observed after WBV.
A recent review (14) reported a beneficial effect of
long-term WBV training on balance control under static
postural conditions. Since the literature appears to suggest a
neuroanatomic (15) and a biomechanical continuum between
standing posture and gait (16–18), Rogan et al. suggested that
this beneficial effect could be extended to dynamic motor tasks
such as gait (14). Such a continuum has been analyzed in stroke
patients (19), for example. The most recent literature review
focusing on the effect of WBV on gait, however, provided
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only mitigated support for this assumption (20). Based on the
screening of 10 randomized controlled trials (RCT), Lindberg
and Carlsson concluded there was low-quality evidence for the
beneficial use of long-term WBV on gait, and acknowledged
there were major limitations (20), the most important being that
only one of the authors reviewed the literature. Thus, no group
discussions were conducted with experts to resolve possible
disagreements and reach a mutual consensus. In addition, the
low number of RCT included (n = 10) and the absence of
meta-analysis may have limited the relevance of Lindberg and
Carlsson’s review. Since that review was published,WBV training
has been used increasingly in physiotherapy to prevent and/or
treat gait disorders. Consequently, more and more experimental
studies have been conducted in this area with both healthy and
pathological participants.
Hence, the aim of this article is to provide an up-to-date
literature review of RCT studies on the effects of long-term
WBV training on gait in both healthy subjects and pathological
patients. It will contribute to provide evidence-based practice for
a promising non-pharmacological rehabilitative method that is
both safe and cheap, and that can be used by patients at home as
part of an auto-rehabilitation program.
MATERIALS AND METHODS
Design and Literature Screening
The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) methodology was employed in this
systematic review (Figure 1).
The PubMed, Science Direct, Springer and Sage databases
were used for a comprehensive systematic literature search
for articles published prior to 7 December 2018 with no
time limit. The keywords used were: “vibration” AND (gait
OR walk). More specifically, the search details specified in
PubMed were: (“vibration”[MeSH Terms] OR “vibration”[All
Fields]) AND ((“gait”[MeSH Terms] OR “gait”[All Fields])
OR (“walking”[MeSH Terms] OR “walking”[All Fields] OR
“walk”[All Fields])).
The selection procedure was conducted by two experts in
rehabilitation. Disagreements were discussed with a third expert
in a group until a mutual consensus was reached. First, a
review was performed on all available titles obtained from
the literature search with the selected keywords. All relevant
or potentially relevant titles were included in the subsequent
phase. Then, the abstracts were reviewed with all relevant
or potential articles included in the following phase. Finally,
full-text articles were reviewed to ensure that only relevant
studies were included. In the same way, reference lists of all
included articles were reviewed to possibly include articles
through cross-referencing.
Inclusion and Exclusion Criteria
To be included, the studies had to meet all of the following
inclusion criteria: all patient categories were selected if: gait
ability was measured before and after at least 4 weeks of WBV
training performed on a vibration platform; the results were
based on biomechanical analyses or were clinically relevant;
the control group had no intervention or performed the same
physical rehabilitation, resistance, balance or endurance training
as the intervention group. In addition, only RCT, articles
in English, and articles published in peer-reviewed journals
were included. Studies were excluded if they measured only
short-term effects (< 4 weeks) and if WBV was combined
with non-physical training or with any intervention not
provided to the control group (i.e., not only WBV effects
are measured).
Data Extraction and Main Measurements
Examined
Data were extracted from the selected articles by one of the
authors. The extracted data were checked by another author and
disagreements were resolved with a third.
The following data were extracted for each selected article:
(1) the names of the authors and the date of publication; (2)
the number of subjects involved in the experiment with their
characteristics and breakdown in each group; (3) WBV training
details (in the following order: name of theWBV device, duration
of the intervention, number of sessions, types of exercises,
number of vibration sets, exposure duration per set, rest period
between sets, frequency, amplitude and type of vibration) and
control group details; and (4) the main outcomes related to gait
with the main results (e.g., timed up-and-go test, 6-min walk test,
walking speed, etc). When information could not be provided, it
was indicated by a “?”.
Quality and Risk of Bias Assessment
The PEDro scale was used to assess the risk of bias, and thus
the methodological quality of the selected studies (21). The scale
was chosen for its ability to provide an overview of the external
(criterion 1), internal (criteria 2–9) and statistical (criteria 9 and
10) validity of RCT. The scale is divided in 11 criteria, but the
first criterion is not calculated in the total score. The output
of each criterion could be either “yes” (y), “no” (n) or “do not
know” (?). A “y” was given a score of one point, while a “n”
or “?” was assigned zero points. Studies with a total score of 5–
10/10 (≥ 50%) were considered to be of high quality, and scores
of 0–4/10 (<50%) as low quality (20). Two evaluators assessed
the quality of the included studies independently. In the event of
disagreements, a group discussion was held with a third expert to
reach a mutual consensus.
Statistical Analysis
To estimate the effect of WBV training on human gait, a meta-
analysis compared the intervention groups with the control
groups. Within group comparisons were added (i.e., pre vs.
post intervention) when the groups were not comparable (e.g.,
statistical difference in outcomes at baseline or additional
training in control group not provided in the intervention
group). Estimations were calculated using the methodology
described by Wan et al. (22) when mean and standard
deviations were not reported by the authors and medians and
interquartile ranges were used. The authors were contacted to
request additional data when an estimation was not possible.
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FIGURE 1 | PRISMA flow chart of study selection process.
If no response was received, the variables were excluded
from meta-analysis.
Statistical analysis and figures (i.e., forest plot to facilitate the
visualization of values) were produced using a random-effect
model in Review Manager software (RevMan, v 5.3, Cochrane
Collaboration, Oxford UK) (23). A random-effect model was
used to take into account the heterogeneity between the study
effects. The effect size of the interventions was reported by
standard mean difference (SMD) and their respective 95%
Confidence Interval (CI). In this way, the magnitude of the
overall effect can be quantified as very small (<0.2) small (0.2–
0.49), moderate (0.5–0.79) or large (≥0.8) (24, 25). Statistical
heterogeneity was calculated using the I2 and Cochrane Q
statistic tests (25). Statistical significance was set at p < 0.05.
Level of Evidence
The strength of evidence of primary outcomes was established as
described by Van Tulder et al. (26) based on the results of meta-
analysis (effect size), statistical heterogeneity (I2) and risk of bias
(PEDro scale). The level of evidence was considered strong with
multiple high-quality RCT (at least two studies with a PEDro
score ≥5/10) that were statistically homogenous (I2 p ≥ 0.05).
The level of evidence was considered moderate with multiple
low-quality studies (two studies with a PEDro score <5/10) that
were statistically homogenous and/or one high quality RCT. The
level of evidence was considered limited when only one low
quality RCT was identified. The level of evidence was conflicting
when there were multiple statistically heterogenous studies
(I2 p < 0.05).
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RESULTS
Included Studies
A total of 816 titles were screened in the first search stage, 43
more were included through cross-referencing, and 692 were
excluded because they did not concern our research question.
The main reasons for exclusion were: absence of WBV treatment
(e.g., studies using local vibrations were excluded), measurement
of acute effects, no value for dynamic balance, case studies and
reviews. Following exclusion, 167 studies were considered for an
abstract review. A further 104 were excluded in this second stage
because they did not meet the inclusion criteria. Finally, 63 full-
text articles were assessed for eligibility with 17 not accepted: five
because training lasted< 4 weeks, six because they were not RCT,
four because there were no walking outcomes, one because it
combined WBV training with non-physical therapy and one for
comparing WBV training combined with another intervention
not provided in the control group (meaning that not only WBV
effects weremeasured). Thus, 46 articles were ultimately included
in this systematic review (9, 27–69, 71, 72). A summary of the
study selection is provided in Table 1.
Characteristics of the Populations
A total of 2 029 patients took part in the 46 studies selected in
this review (see Table 1). The sample size ranged from 14 to 159
participants, with a mean age of 60.9 ± 20.0 years, varying from
7.9 years to 83.2 years. With regard to the adult population, 16
studies evaluated the effects of WBV in the elderly (n = 59.8 ±
35.4 subjects) (9, 30–32, 36, 40, 44, 45, 50, 53, 55, 56, 59, 62,
64, 69), four in patients with Chronic Obstructive Pulmonary
Disease (COPD) (n= 42.5± 16.7 subjects) (57, 61, 65, 71), seven
in patients with stroke (n = 46.1 ± 27.2 subjects) (28, 35, 38, 51,
54, 67, 72), four in patients with osteoarthritis (OA) (n = 32.2 ±
11.9 subjects) (29, 33, 63, 68), three in postmenopausal women (n
= 40.3± 12.5 subjects) (48, 58, 66), two in patients with multiple
sclerosis (n = 29.5 ± 6.3 subjects) (34, 39) and one in patients
with the following pathologies: incomplete cervical spinal injury
(47), pulmonary arterial hypertension (42), lung transplantation
(43), idiopathic Parkinson’s disease (41), total knee arthroplasty
(49) and cerebral palsy (27) (n = 30.0 ± 26.4 subjects). With
regard to the child population, two studies evaluated the effects of
WBV in cerebral palsy (37, 60), one in patients with osteogenesis
imperfect (46) and one in patients with spastic diplegia or
quadriplegia forms of cerebral palsy (52) (n= 22.5±5.9 subjects).
Most of the studies included both males and females, except
for nine studies that either did not mention the participants’
gender or selected only males or females (including the three
studies on post-menopausal women). Most of the studies clearly
explained their eligibility criteria and had similar baselines (no
significant differences between groups in any outcomes before
the intervention) in their groups, except in 10 articles.
Training Protocols
The duration of the WBV training interventions ranged from
four to 32 weeks, with between two and five sessions per
week, with a mean of 3.1 ± 0.8 (three sessions per week in
31 of the 46 selected articles). The frequency and amplitude
used in the training sessions ranged from 2 to 45Hz and
from 0.44 to 20mm, respectively. The intensity of the training
sessions, by frequency and/or amplitude, was progressively
increased in 30 studies, and remained unchanged in the other
selected studies. Some WBV platforms delivered the vibrations
alternating between the right and the left foot, while the right
and left foot moved up and down at the same time in other
vibration plates (70). Synchronous vibrations were delivered in
20 studies, side-alternating vibrations were used in 11 studies,
while 15 studies did not mention the type of vibration in their
intervention method.
For the groups that were exposed to WBV training
(interventions groups), vibrations were delivered while
participants stood in static positions (e.g., squat or lunge
positions) in 27 studies and dynamic exercises were provided
in 11 studies. In the remaining eight studies, both static and
dynamic exercises were combined during the WBV training
sessions. The number of WBV sets per training session ranged
between 1 and 135. The duration of the vibration sets ranged
from 10 s to 3min, with a between-sets resting time ranging
between 3 s and 5min. For the groups not exposed to WBV
training interventions (control groups), participants performed
strengthening and balance exercises without WBV in fourteen
studies, had no intervention and were asked to maintain
their habitual lifestyle in sixteen studies, were exposed to a
sham intervention in six studies, continued to follow their
conventional physiotherapy in four studies, received relaxation
exercises in four studies and performed walking training sessions
in two studies.
Gait Motor Outcomes
The “Timed Up-and-Go” (TUG) test and the “six-minute
walking test” (6MWT) were the clinical outcomes most
frequently used to assess gait (in 29 and 18 studies, respectively).
The “ten-meter walking test” (10MWT) was used in 10 studies
to assess gait velocity. Walking speed was also evaluated using
biomechanical and kinematic assessments (e.g., walking on a
platform or camera motion analysis) in six studies. Other
temporal and spatial parameters such as time of swing phase and
stance phase, stride length and step length were presented in only
two studies. Gait quality was assessed using the gait score of the
Tinetti test in five studies. Finally, other outcomes were used once
in all 46 studies: the “functional ambulation categories test” with
stroke patients, the “50-foot walking test” with knee OA patients,
the “25-foot walking test” with multiple sclerosis patients, the
“two-minute walking test” with knee OA patients, and the time
to walk four meters in postmenopausal women. A summary of
the primary outcomes related to gait is provided in Table 1.
Quality Assessment
The results from the quality assessments for each of the
studies for respective quality indexes are provided in Table 2.
According to the PEDro Scale, 40 studies obtained a high-quality
methodology score while six studies were rated as low quality.
The mean score was 5.8± 1.4 with a median of 5.5 and a range
of scores from 3 to 9. The highest-quality methodology scores
were found in the articles concerning stroke patients, with amean
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TABLE 1 | Descriptive checklist of the included studies.
Article Subjects Interventions Outcomes (only intergroup differences
are presented)
OLDER ADULTS
Lam et al. (50) 73 older adults, 40 women, mean age:
82.3 ± 7.3 years.
WBV + exercise (WBV+E): n = 25, 12
men, 13 women, mean age 84 years
Exercise: n = 24, 10 men, 14 women,
mean age 82.4 years.
Control: n = 24, 11 men, 13 women,
mean age 80.3 years.
8weeks, 3 times per week.
WBV + E: Fitvibe medical WBV system
(GymnaUniphy NV, Bilzen, Belgium),
dynamic exercises, 4 × 1min/1–2min,
30Hz (weeks 1–4) and 40Hz (weeks 5–8),
0.9mm, vertical displacements.
Exercise: identical exercise program
without WBV.
Control: social and recreational activities
that only involved the upper limbs.
WBV + E vs. Exercise: No significant
effect for TUG (SMD = −0.18, 95% CI:
−0.74, 0.38) and the 6MWT (SMD = 0.21,
95% CI: −0.35, 0.78).
Wei et al. (69) 80 community dwelling seniors with
sarcopenia.
Low frequency group: n = 20, 7 men, 13
women, mean age 78 years
Medium frequency group: n = 20, 7 men,
13 women, mean age 75 years
High frequency group: n = 20, 5 men, 15
women, mean age 74 years
Control group: n = 20, 5 men, 15 women,
mean age 76 years
3 days/week over a 12-week period,
WBV: 4mm for all training groups, knee
joint flexed at 60◦, Fitvibe excel,
GymnaUniphy NV, Bilzen, Belgium, vertical
vibrations.
Low frequency group: 20Hz × 720s
Medium frequency group: 40Hz × 360s
High frequency group: 60Hz × 240s
Control group: no extra training
Low frequency group vs. control: no
significant difference for the TUG test
(SMD = −0.22, 95% CI: −0.84, 0.41)
Medium frequency group vs. control: no
significant difference for the TUG test
(SMD = −0.40, 95% CI: −1.03, 0.22)
High frequency group vs. control: no
significant difference for the TUG test
(SMD = −0.30, 95% CI: −0.92, 0.33)
Goudarzian et al. (45) 42 healthy old men.
WBV: n = 11, mean age 66, 58 years.
MT: n = 12, mean age 69, 20 years.
WBV+MT: n = 10, mean age 67, 80
years.
Control: n = 9, mean age 68, 90 years.
3 times a week, 8 weeks
WBV: Novotec, Pfor- zheim, Germany,
static and dynamic exercises, 6 ×
45–85s/45–85s, 30–35Hz, 5–8mm, n
MT: relaxation techniques.
WBV+MT: combination of vibration and
MT that was the half-time of each
protocol.
Control: Daily routine.
WBV vs. Control: no difference between
group for the TUG test (SMD = −0.60,
95% CI: −1.50, 0.31).
Significant improvement of the 10MWT in
favor of the WBV (SMD = −1.32, 95% CI:
−2.32, −0.33).
Sitjà-Rabert et al. (64) 159 older people, 107 women, 52 men,
with a mean age of 82 years.
WBV + exercise group: n = 81, n
Exercise group: n = 78, n
6 weeks, 3 sessions per week.
WBV + exercise group: Pro5 Airdaptive
Model; PowerPlate, Amsterdam, The
Netherlands, static/dynamic exercises, n,
30–35Hz, 2–4mm, n
Exercise group: same static/dynamic
exercises without vibration platform.
WBV + exercise group vs. exercise group:
No difference between group for the TUG
test (SMD = −0.02, 95% CI: −0.39, 0.34)
No difference between group for the
Tinetti gait score (SMD = −0.08, 95% CI:
−0.44, 0.27)
Santin-Medeiros et al.
(62)
37 elderly women, mean age 82.4 years.
WBV group: n = 25.
Control group: n = 18.
8-month, 2 sessions per week
WBV: Fitvibe Excel Pro; GymnaUniphy NV
Bilzen, Belgium,18 exercises, 6/session,
1–2 sets/exercise, 30–35/exercise, 6
min-6 min50 s/ session, 20Hz, 2mm.
Control: maintain their habitual lifestyle
WBV vs. control: Groups were statistically
different at baseline for the TUG test.
WBV: No significant improvement of the
TUG test post WBV (SMD = 0.15, 95%
CI: −0.49, 0.78).
Buckinx et al. (36) 62 nursing home residents.
WBV group: n = 31, 11 men, 20 women,
mean age 82.2 years.
Control group: n = 31, 3 men, 27 women,
mean age 84.2 years.
6 months, 3 training sessions every week.
WBV group: Vibrosphère,
knees flexed, 5 × 15 s/30 s, 30Hz, 2mm,
vertical vibrations.
Control group: normal daily life.
Lack of data post WBV.
WBV vs. control: authors reported no
significant inter group difference for the
TUG test, Tinetti gait score and for the
parameters recorded by the Locometrix (p
> 0.05).
Lee et al. (53) 55 Elderly Patients with Diabetic
Neuropathy
WBV + BE group: n = 19, 9 men, 10
women, mean age 76.31 years.
Balance exercise group (BE): n = 18,
men:7, women:11, mean age: 74.05
years.
Control group: n = 18, 8men, 10 women,
mean age 75.77 years.
6 weeks, twice per week, same physical
therapy.
WBV + BE group: Galileo 2000, Novotec
Medical GmBH, Germany, 3/week,
squatting position, 3× 3min/1-min,
15-30Hz, 1–3mm, n
BE group: strength, balance, and
functional mobility training.
Control group: n
WBV + BE group vs. BE group:
Significant improvement of the TUG test in
favor of the WBV group (SMD = −0.72,
95% CI: −1.39, −0.06).
(Continued)
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TABLE 1 | Continued
Article Subjects Interventions Outcomes (only intergroup differences
are presented)
Beaudart et al. (31) 62 nursing home residents.
WBV group: n = 31, 11 men, 20 women,
mean age 82.2 years.
Control group: n = 31, 4 men, 27 women,
mean age 84.2 years.
3 months, 3 training sessions every week.
WBV: Vibrosphere, static position with a
knee flexion, 5 × 15/30 s, 30Hz, 2mm,
vertical vibrations.
Control group: requested neither to
change their lifestyle during the study nor
to get involved in any new type of
physical activity.
WBV vs. control:
No significant difference between groups
for the TUG test (SMD = −0.10, 94% CI:
−0.59, 0.40) and the Tinetti test (SMD =
0.30, 95% CI: −0.20, 0.80).
Lack of data post WBV for the Locometrix
system.
The authors reported no significant inter
group difference for the parameters
recorded by the Locometrix (p > 0.05).
Gómez-Cabello et al.
(44)
49 non-institutionalized elderly (20 men
and 29 women; aged 75.0 ± 4.7 years).
WBV: n = 24, n
Control: n = 25, n
11 weeks, 3 times per week.
WBV: Pro5 Power plate, London, UK,
squat position, 10 × 45/60s, 40Hz, 2mm.
Control: not participate in any training.
Asked not to change their lifestyle.
WBV vs. control: No difference between
group for the 6MWT (SMD = 0.54, 95%
CI: −0.03, 1.11).
Bogaerts et al. (32) 111 elderly women over 70 years of age
WBV group: n = 54
Control group: n = 57
6 mouths, 3 sessions per week;
WBV group: Powerplate, 2–5 dynamic
exercises. 4 × 15s/60s (start of the study),
12 × 60s//5s (6mouths). 30-40HZ,
1,6–2,2g, n
Control group: no training program.
WBV vs. control group: No significant
difference for the TUG test (SMD = −0.18,
95% CI: −0.55, 0.20) and the 10MWT
(SMD= −0.26, 95% CI : −0.63, 0.12) at
preferred speed.
No significant difference for the TUG test
(SMD = −0.31, 95% CI: −0.68, 0.07) and
the 10MWT
(SMD = −0.10, 95% CI: −0.47, 0.27) at
maximum speed.
Mikhael et al. (56) 19 older adults mean age 64, 4 years
(range 50–80).
WBV with flexed knees (FK): n = 6, 4 men,
2 women, mean age 63.3 years
WBV with locked knees (LK): n = 5, 3
men, 2 women, mean age 69 years
Sham: n = 8, 4 men, 4 women, mean age
62.3 years
20min, 3 days per week, 3 months, static
exercises, 39 × 1min/1min, 12Hz, 1mm
WBV with FK: vibration platform
engineered by Australian Catholic
University (2004), knee angle at 20
WBV with LK: lock knees
Sham: The amplitude was set to 0mm,
giving 0 g magnitude.
Lack of data post WBV.
The authors reported no between groups
difference after WBV for the 6MWT (p =
0.61), habitual and maximal gait velocities
(p = 0.80 and p = 0.58, respectively).
Machado et al. (55) 26 community-dwelling elderly women
WBV: n = 13, mean age 79.3 years
Control: n = 13, mean age 76.2 years
3–5 times a week, 10 weeks
WBV: Fitvibe, GymnaUniphy NV, Bilzen,
Belgium, half squat, deep squat, wide
stance squat, calves, 1–2 sets/exercise,
30–60 s/120–180 s, 2–4mm, 20–40Hz,
increased progressively, n
Control: requested to do not change their
lifestyle during the study
Lack of data post WBV. The authors
reported a significant improvement of the
TUG test post WBV(p < 0.05) but no
significant difference between groups (p
> 0.05).
Furness and
Maschette. (40)
73 older adults, 38 females and 35 males,
mean age 72 ± 8 years
1 WBV session per week: n
2 WBV sessions per week: n
3 WBV sessions per week: n
Control group: n
0, 1, 2, or 3 times a week, 6 weeks.
WBV interventions: n, static, knees flexes
at 110◦, 5 × 1min/1min, 15–25Hz,
0,5mm, vertical vibrations.
Control group: The zero group did not
participate in any WBV sessions.
1 WBV vs. control: No significant between
group difference for the TUG test (SMD =
0.57, 95% CI : −0.10, 1.24)
2 WBV vs. control: No significant between
group difference for the TUG test (SMD =
0.57, 95% CI: −0.10, 1.24)
3 WBV vs. control: No significant between
group difference for the TUG test (SMD =
−0.45, 95% CI: −1.11, 0.20)
Rees et al. (59) 43 older adults, untrained, 23 men and 20
women
WBV group: n = 15, mean age 74.5 years
Exercise group: n = 13, mean age 73.1
years
Control group: n = 15, mean age
73.1 year
3 sessions a week, 8weeks, low- intensity
walking at least 3 times a week
WBV group: Novotec, Pforzheim,
Germany, static and dynamic exercises, 6
× 45–80s/45–80s, 26Hz, 5–8mm,
increased progressively, vertical
displacements.
Exercise group: same exercises without
WBV.
Control group: low intensity walking
WBV vs. exercise group:
No significant difference between groups
for the TUG test (SMD = −0.35, 95% CI:
−1.10, 0.40) and the 10MWT (SMD =
−0.25 95% CI: −0.99, 0.50).
WBV vs. control: no significant difference
between group for the TUG test (SMD =
−0.22, 95% CI: −0.75, 0.31) and the
10MWT test (SMD = −0.29, 95% CI:
−1.01, 0.43).
(Continued)
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Bautmans et al. (30) 24 older adults, nursing home residents.
WBV: n = 13, 5 men, 8 women, mean age
76.6 years.
Sham: n = 11, 4 men, 7 women, mean
age 78.6 years.
3 times weekly, 6 weeks
WBV: Power- Plate, Badhoevedorp, The
Netherlands, 2–4 static lower limb
exercises/sessions, 1–3 ×
30–60s/30–60s, 35–40Hz, 2–5mm,
increased progressively, vertical vibrations.
Sham: same exercise program on the
vibration plate, but without
vertical vibrations.
WBV vs. sham: No significant difference
between groups for the TUG test (SMD =
−0.38, 95% CI: −1.25, 0.48) and the
Tinetti test (SMD = 0.00, 95%
CI:−0.86, 0.86).
Bruyere et al. (9) 42 older adults, nursing home residents
WBV + Physical therapy: n = 22, 4 men,
18 women, mean age 84.5 years
Physical therapy: n = 20, 7 men, 13
women, mean age 78.9 years
3 times a week, 6 weeks, same PT 10min
WBV + Physical therapy: n static exercise,
4 × 60 s/90 s, 10–26Hz, 3–7mm, vertical
vibrations.
Physical therapy: PT only.
Lack of data post WBV. Groups were
statistically different at baseline for the
TUG test (p = 0.04).
The authors reported a significant
decrease of 11.0 ± 8.6 s post WBV for the
TUG test and an increase of 3.5 ± 2.1
points post WBV for the Tinetti gait score.
PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Spielmanns et al. (71) 28 subjects with COPD stage II-IV.
WBVT group: n = 12, 8 men, 4 women,
mean age 62.4 years.
Conventional training group (CTG): n = 16,
9 men, 7 women, mean age 68 years.
3 months, 2 sessions/week, same
resistance, and endurance training.
WBVT group: Galileo vibration platform
(No- votec Medical, Pforzheim, Germany),
3 × 20 squat repetitions, 24–26Hz, 3mm,
side-alternating vibration.
CTG: same of squat exercises but
without WBVT.
WBV vs. control: no significant difference
between groups for the 6MWT (SMD =
0.72, 95% CI:−0.05, 1.50).
Spielmanns et al. (65) 29 subjects with stable COPD in stage I to
III
WB group: n = 14, 7 men, 7 women,
mean age 69 years.
Calisthenics group: n = 14, 7 men, 7
women mean age 70 years.
3 months, twice per week.
WBV group: Galileo, Novotec Medical,
Pforzheim, Germany, isometric squat
position, 3 × 2 min/2min, 6 −10Hz,
4–6mm, side-alternating vibration.
Calisthenics group: relaxation, breathing
retraining, calisthenics exercises.
WBV vs. Calistenic: no significant
difference between groups for the 6MWT
(SMD = 0.54, 95% CI:−0.23, 1.32).
Salhi et al. (61) 62 patients with COPD
WBV-group: n = 31, 21 men, 10 women,
mean age 58 years.
Conventional resistance training (RT): n =
31, 23 men, 8 women, mean age
63 years.
12 weeks, 3 times a week, same
pulmonary rehabilitation program.
WBV-group: FITVIBE, Gymna, Belgium, 8
upper and lower body exercises, 1–3
sets/exercise, 30–60s/n 27Hz, 2mm,
vertical vibrations.
RT: lower and upper body exercises, 3
× 10repetitions
WBV vs. RT: no significant difference
between groups for the 6MWT (SMD =
−0.24, 95% CI: −0.79, 0.31)
Pleguezuelos et al. (57) 51 stable male patients with COPD
Whole Body Vibration Training Group: n =
26, mean age 68.4 years.
Control group: n = 25, mean age
71.3 years.
6 weeks, 3 sessions per week, regular
prescribed medical treatment.
WBVTG: Gymnauni phy. Nv. Pasweg 6a
3740 Bilzen, Belgium, squatting position,
6 × 30s/60s, 35Hz and 2mm, vertical
vibrations.
Control Group: general recommendations
about physical activity and lifestyle.
WBV vs. control: no significant difference
between groups for the 6MWT (SMD =
2.59, 95% CI 1.83, 3.35).
STROKE
Alp et al. (28) 21 post stroke patients
WBV: (n = 10), 10 men, 0 women, mean
age 61.20 ± 11.043 years.
Control group: (n = 11) 9 men, 2 women,
mean age 62.9 ± 8 years
4 weeks, 3 days a week, stretching and
active range of motion exercises on the
hemiplegic lower extremity for 15min.
WBV: Compex Winplate by Uniphy
Elektromedizin GmbH and CoKG, tiptoes,
3 × 10s/3–20 s, 5min, 40Hz, 4mm,n
Control group: same exercises,
no vibration.
Lack of data post WBV. The groups were
statistically different at baseline for the
10MWT (p < 0.001).
The authors reported a significant
improvement of the 10MWT in favor of the
WBV group (p < 0.001).
(Continued)
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Choi et al. (72) 30 individuals who presented with a gait
deviation after a first stroke (>6 months).
WBV-Treadmill Training (TT): n = 15, 8
men, 7 women, mean age 51.93 years.
TT group: n = 15, 11 men, 4 women,
mean age 53.67 years.
6 weeks, 3 times a week, 20min of TT for
both groups.
WBV- TT: Galileo 2000, (Novotec,
Germany, 2011), dynamic exercises, 6 ×
45s/1min20-30HZ, 3mm, side-
alternating vibration.
TT group: same exercises on the platform
without vibration.
No significant difference between group
for the Walking speed (SMD = 0.32, 95%
CI: −0.40, 1.04) and stride length (SMD =
0.50, 95% CI: −0.23, 1.23).
Choi et al. (38) 22 individuals who were diagnosed with
strokes at least 6 months prior to the
study.
WBV group: n = 11, 8 males, 3 females,
mean age 50.9 years.
Control group: n = 11, 7 males, 4 females,
mean age 52.2 years.
4 weeks, 5 times per week.
WBV group: Galileo tilt table (Novotec
Medical, Germany), squat posture, 10
min/session, 25Hz, 5mm,n
Control group: 30min of
Neuro-developmental treatment as the
experimental group.
WBV vs. control group: no significant
difference between group for the TUG test
(SMD = −0.50, 95% CI : −1.35, 0.35).
Liao et al. (54) 84 individuals with hemispheric stroke
persisting for more than 6 months before
the time of enrolment
low-intensity WBV group (LWBV): n = 28,
20 men, 8 women, mean age 60.9 years
High-intensity WBV group (HWBV): n =
28, 18 men, 10 women, mean age 62.9
years
Control (CON): n = 28, 24 men, 4 women,
mean age 59.8 years.
3 times a week, 30 sessions, same
dynamic and static exercises, Gymna
Fitvibe Medical System, Gymna Uniphy
Pasweg, Bilzen, Belgium, synchronous
vibrations.
LWBV: 20Hz, 1mm
HWBV: 30Hz, 1mm
Control (CON): standing on the same WBV
platform turned off.
LWBV vs. control: no significant difference
between group for the 6MWT (SMD =
0.05 95% CI:−0.47, 0.58) and for TUG
test
(SMD = −0.10 95% CI: −0.62, 0.43).
HWBV vs. Control: no significant difference
between group for the 6MWT (SMD =
−0.03, 95% CI−0.55, 0.50) and for TUG
test (SMD = −0.25, 95% CI: −0.77, 0.28).
Lau et al. (51) 82 chronic stroke patients.
WBV group: n = 41, 26 men, 15 women,
mean age 57.3 years.
Control group: n = 41, 32 men, 9 women,
mean age 57.4 years.
8 weeks, 3 times a week.
WBV: Jet-Vibe System (Danil SMC Co.
Ltd., Seoul, South Korea), dynamic leg
exercises, 6 exercises, 9–15 × 1,5-2,
5min/n, 20–30Hz, 0.44–0.60mm, vertical
vibrations.
Control group: same exercises
without vibration.
WBV vs. control: no significant
improvement of the 6MWT
(SMD = −0.22 95% CI = −0.66, 0.21)
and the 10MWT (SMD = 0.39 95% CI:
−0.05, 0.83).
Brogårdh et al. (35) 31 individuals with chronic stroke.
WBV: n = 16, 13 men, 3 women, mean
age 61.3 years.
Control group: n = 15, 12 men, 3 women,
mean age 63.9 years.
6 weeks, 2 sessions/week.
WBV training: Xrsize, static position knee
flexed, 4–12 × 40–60s/1min, 25Hz,
3.75mm, vertical vibrations.
Control group: placebo vibrating platform
(25Hz, 0.2mm amplitude).
WBV vs. control group: groups were
different at baseline for the TUG test and
the 6MWT.
The authors reported significant
improvements in both outcomes after
WBV (p < 0.05)
van Nes Ilse et al. (67) 53 post-stoke patients
WBV group: n = 27, 16 males, 11
females, mean age of 59.7 years.
Exercise therapy on music group: n = 26,
14 males, 12 females, mean age of
62.6 years.
6 weeks, 5 days per week, physical
therapy
WBV group: Galileo 900, Galileo 2000,
Enschede, The Netherlands, squat
position hips and knees slightly flexed, 4 ×
45 s/60 s, 30Hz, 3mm, Side-alternating
vibration.
Exercise therapy on music group: same
standing position, exercises
and relaxation.
WBV vs. exercise therapy on music group:
no significant difference between groups
(SMD = 0.00, 95% CI: −0.54, 0.54).
KNEE OSTEOARTHRITIS
Bokaeian et al. (33) 28 patients with knee osteoarthritis.
WBV + Strength Training (ST): n = 15, 0
men, mean age 51.8 years
Strength Training: n = 13, 2 men, 11
women, mean age 54 years.
8 weeks, 3 times a week, both groups
received same PT and strengthening
exercises protocol.
WBV + ST group: Fitvibe device (Italy),
bent knees, 6–9 × 30–70 s/30–70 s,
25–30HZ, 2mm, progressively increased,
vertical vibrations.
Strength Training: flexion and extension
exercise of knee joint, 3 sets, 10 RM,
progressive load.
Lack of data post WBV. The authors
reported significant improvements for the
2MWT, 50FWT and TUGT in favor of the
WBV + ST group (p = 0.009).
(Continued)
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Wang et al. (68) 49 patients with knee osteoarthritis.
Whole Body Vibration Exercise +
Quadriceps Resistance Exercise group: n
= 49, 13 men, 36 women, mean age 61.2
years.
Quadriceps Resistance Exercise only
group: n = 50, 15 men, 35, women, mean
age 61.5 years.
24 weeks, 5 days/week.
WBV + QRE: My7TM model Personal
Plate, Power Plate, USA, knees slightly
flexed, 30 × 60 s/60 s, 35Hz, 4–6mm,n
Quadriceps Resistance Exercise: static
and dynamic exercises.
WBV + QRE vs. QRT: significant
improvement in favor of the WBV+QRE
group for the TUG test (SMD = −3.11
95% CI: −3.71, −2.52) and the 6MWT
(SMD = 1.68, 95% CI : 1.22, 2.14)
Simão et al. (63) 31 elderly subjects with knee
osteoarthritis.
WBV group: n = 10, mean age 75 years.
Squat group: n = 10, mean age 73.4
years.
Control group: n = 11, mean age 71 years.
12 weeks, 3 times per week.
WBV group: FitVibe, squat exercise, 6–8
× 20–40 s/20–40 s, 35–40HZ, 4mm,
vertical vibrations.
Squat group: 3s of isometric contraction.
Control group: without intervention. No
change their lifestyle.
WBV vs. Control group: no significant
difference between groups for the 6MWT
(SMD= 0.56, 95% CI: −0.26, 1.37) and
gait speed (SMD= 0.39, 95%
CI−0.42, 1.20).
Avelar et al. (29) 21 elderly patients with knee osteoarthritis.
WBV group: n = 11, mean age 75 years.
Control group: n = 10, mean age 71 years.
12 weeks, 3 times per week.
WBV: FitVibe, GymnaUniphy NV, Bilzen,
Belgium, squat training with WBV, 6–8 ×
20–40 s/20–40 s, 35 Hz−40Hz, 4mm, n
Control: squat training without vibration.
WBV vs. control group: no significant
difference between groups for the TUG
test (SMD = 0.06, 95% CI: −0.80, 0.91).
Significant improvement of the 6MWT in
favor of the WBV group (SMD = 1.49,
95% CI: 0.49, 2.48).
POSTMENOPAUSAL WOMEN
Sucuoglu et al. (66) 42 postmenopausal women patients
WBV- Balance Coordination Exercise
(BCE) group: n = 21, mean age 56 years.
BCE group: n = 26, mean age
58.76 years.
4 weeks, 10 sessions per week, identical
BCE programs.
WBV-BCE group: Power Plate
(Performance Health Systems UK Ltd,
London, UK), 3 static positions, 2 × 30
s/60 s 30–35Hz. 5 sessions per week,
vertical vibrations.
BCE group: 20-min exercise sessions at
home, twice per day.
Significant difference at baseline between
groups for the TUG test.
The authors reported significant
improvement compared with pretreatment
values in both groups (p < 0.005).
Iwamoto et al. (48) 52 ambulatory postmenopausal women
with osteoporosis.
WBV group: n = 26, mean age 72.4
years.
Control group: n = 26, mean age 76 years.
6 months, n
WBV group: Galileo machine (G- 900;
Novotec, Pforzheim, Germany), bent
knees, 4min, 20HZ, n, side to side
alternating vibrations.
Control group: no exercise.
Lack of data post WBV.
The authors reported no significant
difference between groups for the TUG
test (p > 0.05) but significant improvement
in favor of the WBV group for the 10MWT
(p < 0.05).
Raimundo et al. (58) 27 postmenopausal women
WBV: n = 14, mean age 66 years
Walk based program: n = 13, mean age
66 years.
3 times a week, 8 months
WBV: Galileo 154 2000, Novotec GmbH,
Pforzheim, Germany, static knees flexed at
120◦, 3–6 × 1 min/1min, 12,6Hz, 6mm,
increased each week, side-alternating
oscillations.
Walk based program: 2 × 25min of walk,
70–75% HRmax
Lack of data post WBV. The authors
reported a significant improvement of the
10MWT post WBV (p = 0.006).
MULTIPLE SCLEROSIS
Ebrahimi et al. (39) 34 multiple sclerosis patients with mild to
moderate disability
WBV group: n = 17, 5 men, 12 women,
mean age 37.06 years.
Control group: n = 17 4 men, 13 women,
mean age 40.75 years.
10 weeks, 3 times a week.
WBV group: n, static positions, 15 ×
30s−2 min/30 s−5min, 2–20Hz, 2mm, n
Control group: continued their normal life
WBV vs. control group: no significant
difference between groups for the TUG
test (SMD = −0.47, 95% CI: −1.20, 0.26).
Significant improvement in favor of the
WBV group for the 10MWT (SMD =
−1.05, 95% CI: −1.82, −0.28) and the
6MWT (SMD = 1.22, 95% CI: 0.43, 2.01).
Broekmans et al. (34) 25 ambulatory community- based patients
with multiple sclerosis.
WBV: n = 11, 7 men, 4 women, mean age
46.1 years
Control: n = 14, 11 men, 3 women, mean
age 49.7 years
5 sessions per 2-week cycle, 20 weeks
WBV: Alpha Vibe Nijverdal, The
Netherlands, 2–5 static and dynamic leg
squats and lunges, 1–3 × 30–60
s/30–120 s, 20–45Hz, 2.5mm, increased
progressively, vertical vibrations.
Control: maintain their usual lifestyle
Groups were statistically different at
baseline for the TUG test and 2MWT.
The authors reported no significant effects
in both groups for the TUG test (p = 0.26)
and the 2MWT (p = 0.25).
(Continued)
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OTHER PATHOLOGIES IN ADULTS
In et al. (47) 28 patients who were diagnosed with
incomplete cervical spinal injury
WBV group: n = 14, 9 men, 5 women,
mean age 46.1 ± 9.8 years
Control group: n = 14, 10 men, 4 women,
mean age 49.9 ± 9.3 years
8 weeks, 5 days a week, twice a day,
conventional physical therapy
WBV group: TT2590X7, TurboSonic Co.,
South Korea, semi-squat with slight flexion
(140◦) at hips, knees and ankles, 4 × 45
s/1min, 30Hz, 2–4mm, vertical vibrations.
Control group: 16min of placebo WBV
and 30min of physical therapy.
WBV vs. Control group: No significant
difference between groups for the TUG
test (SMD = −0.64, 95 CI: −1.40, 0.13)
and the 10MWT (SMD = −0.23, 95%
CI:-0.97, 0.52).
Gerhardt et al. (42) 22 adult patients with stable, symptomatic
pulmonary arterial hypertension (PAH).
WBV group: n = 11, 7 men, 4 women,
mean age 65.1 years.
Control group: n = 11, 6 men, 5 women,
46 years.
4 weeks, 16 sessions.
WBV group: Galileo MedM plat- form
(Novotec Medical GmbH, Pforzheim,
Germany), specific coordination exercises,
n, 20Hz, 20mm, side alternating
vibrations.
Control group: received WBV in a
second phase.
Lack of data post WBV. The authors
indicated that WBV was associated with a
significant improvement of the 6MWD
versus baseline of +38.6 ±6.6m (p
< 0.001)
Gloeckl et al. (43) 83 patients after lung transplantation.
WBVT group: n = 34, 16 men, 18 women,
mean age 56 years.
Control group: n = 36, 22 men, 14
women, mean age 56 years.
4 weeks, 3 times per week, same
pulmonary rehabilitation program.
WBVT group: GALILEO, Novotec Medical
GmbH, Pforzheim, Germany, squat
exercises, 4 × 2min/4min, 24–26Hz,
6mm, side alternating vibrations.
Control group: same squat training on
the floor.
lack of data post WBV
The authors reported a between group
difference of 28m (95%CI: 3m to 54m, p
= 0.029) significantly different in favor
of WBVT.
Gaßner et al. (41) 17 participants diagnosed with idiopathic
Parkinson’s disease.
WBV group: n = 8, 6 men, 2 women,
mean age 71.4 years.
Placebo group: n = 9, 7 men, 2 women,
mean age 68.2 years.
5 weeks, 2–3 times a week.
WBV group: SRT Zeptor Medical plus
noise, static position, 5 × 60 s/60 s, knees
slightly bents, 6Hz, 3mm, n
Placebo group: stood on the vibration
platform in the same basic position.
WBV vs. placebo group: no significant
difference between group for the TUG test
(SMD = −0.37, 95% CI: −1.34, 0.59),
velocity (SMD = −0.21, 95% CI: −1.17,
0.74) and step length (SMD = 0.14, 95%
CI: −0.81, 1.09).
Johnson et al. (49) 16 individuals, 3–6 weeks post total knee
arthroplasty
WBV: n = 8, 6 men, 2 women, mean age
67 years
Traditional Progressive Resistance
Exercise (TPRT): n = 8, 4 men, 4 women,
mean age 68.5 years
3 session a week, 4 weeks
WBV: Power Plate, Badhoevendorp, The
Nertherlands, static and dynamic
exercises, 4–6 exercises/session, 1–3
set/exercise, 30–60 s/n,35Hz, 2–5mm, n
TPRE: 1–3 SET of 10 REP for
strengthening exercises for lower limbs,
exercises were progressed once the
patient could complete the exercise
WBV vs. TRPE: no significant difference
for the TUG test (SMD = −0.59, 95% CI:
−1.59, 0.42).
Ahlborg et al. (27) 14 persons with cerebral palsy, spastic
diplegia
WBV: n = 7, 4 men, 3 women, mean age
32 years
Resistance training: n = 7, 4 men, 3
women, mean age 30 years
Three times weekly, 8 weeks, same
warming up and stretching
WBV: NEMES-LSC (Nemesis BV, Hengelo,
The Netherlands), standing position, hips
and knees in 50◦ of flexion, 1–4 × 30–110
s/15–120 s, increased progressively, 11
levels of intensity, 25–40Hz, 7/10 on the
Borg Scale, n
Resistance training: leg press, 3 SET of
10–15 REP, progressive load.
WBV vs. RT: no significant difference
between groups for the TUG test (SMD =
0.28, 95% CI: −0.77, 1.34).
OTHER PATHOLOGIES IN CHILDREN
Högler et al. (46) 24 children (5–16 years) with clinically mild
to moderate osteogenesis imperfecta.
WBV training: n = 12, 6 men, 6 women,
mean age 9.38 years.
Control group: n = 12, 6 men, 6 women,
mean age 6.49 years.
5 months, twice-daily, home use
WBV training: Galileo MTM, Novotec
Medical, Pforzheim, Germany), static and
dynamic exercises, 3 × 3 min/3min,
20–25Hz, side alternating vibrations.
Control group: continued to receive
regular care.
Lack of data post WBV. The authors
reported no significant difference between
groups for the 6MWT (p = 0.278)
(Continued)
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Cheng et al. (37) 16 children with cerebral palsy, 8 boys and
8 girls, mean age 9.2 years.
WBV group: n = 8, n
Control group: n = 8, n
8-week WMV intervention followed by an
8-week control condition, with a 4-week
rest (crossover study).
WBV: AV-001A, Body Green, Taipei,
Taiwan, static position, 10min, 20Hz,
2mm, vertical vibrations.
Control: same procedure with the machine
turned off.
Lack of data post WBV. The authors
reported a significant difference between
the treatment and control condition for the
6MWT (p = 0.005).
Lee and Chon. (52) 30 patients with either the spastic diplegia
or quadriplegia forms of cerebral palsy
WBV group: n = 15, 6 men, 9 women,
mean age 10 years.
Control group: n = 15, 9 men, 6 women,
mean age 9.66.
8 weeks, 3 days per week, conventional
PT.
WBV: Galileo system (Novotec Medical
GmbH, Pforzheim, Germany), squat
position, 6 × 3 min/3min, 5–25Hz,
1–9mm, side alternating vibrations.
Control group: conventional physical
therapy training.
WBV vs. control group:
Significant improvement in favor of the
WBV group for the gait speed (SMD =
1.41, 95% CI: 0.60, 2.22) and stride
length (SMD = 0.91, 95% CI: 0.15, 1.67)
Ruck et al. (60) 20 children with cerebral palsy
WBV: n = 10, 8 boys, 2 girls mean age 8.3
years
Control: n = 10, 6 boys, 4 girls, mean age
8.1 years
Physiotherapy according to the
established school program, 6 months, 5
days per week
WBV: Vibraflex Home Edition II,
Orthometrix Inc, White Plains, NY. Outside
of North America, Galileo Basic, knees and
hips flexed 10–45◦, dynamic exercises, 3
× 3 min/3min, 12–18Hz, 2–6mm, side to
side alternating vertical vibrations.
Control: Physiotherapy only
Lack of data post WBV. The authors
reported a significant improvement of the
10MWT in favor of the WBV (p = 0.03).
WBV, Whole body vibration; TUG, Timed up and go test ; 6MWT, 6-minute walk test; 2MWT, 2-minute walk test; 50FWT, 50-feet walk test; 10MWT, 10-meter walk test.
score of 7.2± 1.7. The poorest methodological quality was found
for postmenopausal women with a mean score of 4.7± 1.1.
Studies Included for Meta-Analysis
A total of 25 studies were included in statistical analysis. Eleven
studies were included for meta-analysis in the elderly (30–32, 40,
44, 45, 50, 53, 59, 64, 69), four studies for COPD patients(57,
61, 65, 71), four studies for stroke patients (35, 38, 51, 54), four
studies for patients with knee OA (29, 33, 63, 68) and two studies
for patients with Multiple Sclerosis (MS) (3, 34).
Results Ranked According to Aging and
Pathology
Elderly Subjects
Sixteen studies examined the effect of WBV on elderly subjects(9,
30–32, 36, 40, 44, 45, 50, 53, 55, 56, 59, 62, 64, 69). The studies
had an average PEDro score of 5.5 ± 1.0. The sample size
ranged from 19 to 159 participants with a mean age of 76.5 ±
5.8 years. Most of the studies included both men and women
except for three with women only (32, 55, 62) and one with
only men (45). Only one study failed to mention the eligibility
criteria (44) and seven studies exhibited heterogeneity in their
baselines (9, 36, 40, 44, 55, 62, 64). Training duration varied
from 6 weeks to 8 months. Fifteen studies had a frequency
of three sessions per week (9, 30–32, 36, 40, 44, 45, 50, 53,
55, 56, 59, 64, 69) while one study involved two sessions per
week (62). The frequency and amplitude of platform vibrations
varied from 10 to 40Hz and 0.5 to 8mm, respectively. Intensity
was progressively increased in 11 studies (9, 30, 32, 40, 45, 50,
53, 55, 59, 62, 64). Eight studies used synchronous vibrations
(9, 30, 31, 36, 40, 50, 59, 69) while the other eight studies
(32, 44, 45, 53, 55, 56, 62, 64) did not mention the type of
vibrations delivered by their devices. The number of vibration
bouts delivered per session varied from two to 39 sets with a
period lasting between 15 sand 3min each. Resting time was
between 5 s and 5min. In nine protocols (9, 30, 31, 36, 40, 44,
53, 56, 69), the subjects maintained a static position, while they
performed dynamic exercises in three studies (32, 50, 55), or
both in four studies (45, 59, 62, 64). The most frequently used
outcome was TUG, found in 14 studies (9, 30–32, 36, 40, 45,
50, 53, 55, 59, 62, 64, 69). Six studies combined TUG with the
Tinetti gait score (9, 30, 31, 36, 40, 64). Four studies assessed
gait speed using the 10MWT (32, 45, 59, 69). Three studies
assessed functional performance with the 6MWT (44, 50, 56).
Two studies used the Locometrix system for biomechanical
analysis (31, 36).
Comparisons to control groups
Four meta analyses (9, 31, 36, 55) were conducted for the
following outcomes: TUG test, 10MWT, Tinetti test and 6MWT.
For the TUG test (Figure 2A), 10 studies were included in
meta-analysis and four studies were excluded due to a lack of
data despite requests to the authors (9, 31, 36, 55). Meta-analysis
showed a significant decrease in time in favor of theWBV groups
(SMD = −0.18; 95% CI: −0.33, −0.04), with consistent results
(I2 = 7%, p = 0.38). The included studies were of high quality
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TABLE 2 | Quality assessment with the PEDro scale.
Article Items by number on the PEDro scale Total score Subjects
1 2 3 4 5 6 7 8 9 10 11
Lam et al. (50) y y y y n n y n n y y 6 Older adults
Wei et al. (69) y y n y n n n y y y y 6
Goudarzian et al. (45) y y n y n n n y n y y 5
Sitjà-Rabert et al. (64) y y y n n n y n y y y 6
Santin-Medeiros et al. (62) y y n n n n n n y y y 4
Buckinx et al. (36) y y n n n n y n y y y 5
Lee et al. (53) y y n y n n n y n y y 5
Beaudart et al. (31) y y n y n n y y y y y 7
Gómez-Cabello et al. (44) n y n n n n n y y y y 5
Bogaerts, et al. (32) y y y y n n n y n y y 6
Machado et al. (55) y y n n n n y y n y y 5
Mikhael et al. (56) y y y y y n y n n y y 7
Furness and Maschette (40) y y n n n n n y y y y 5
Rees et al. (59) y y n y n n n y n y y 5
Bautmans et al. (30) y y y y y n y y n y y 8
Bruyere et al. (9) y y n n n n n y y y y 5
Spielmanns et al. (71) y y y y n n n n n y y 5 COPD
Spielmanns et al. (65) y y n y n n n y n y y 5
Salhi et al. (61) y y y y n n n n n y y 6
Pleguezuelos et al. (57) y y n y n n y n n y y 5
Alp et al. (28) y y y n n n y y n y y 6 Stroke
Choi et al. (72) y y y y n n y y y y y 8
Choi et al. (38) y y n y n n n n n y y 4
Liao et al. (54) y y y y n n y y y y y 8
Lau et al. (51) y y y y n n y y y y y 8
Brogårdh et al. (35) y y y y y n y y y y y 9
van Nes Ilse et al. (67) y y y n y n y y y y y 8
Bokaeian et al. (33) y y y y n n n y n y y 6 Knee OA
Wang et al. (68) y y y y n n y y y y y 8
Simão et al. (63) y y y y n n y y n y y 7
Avelar et al. (29) y y n y n n n y n y y 5
Sucuoglu al. (66) y y n y n n n n n y y 4 Postmenauposal women
Iwamoto et al. (48) y y n y n n n y y y y 6
Raimundo et al. (58) y y n y n n n n n y y 4
Ebrahimi et al. (39) y y n y n n n y n y y 5 Multiple sclerosis
Broekmans et al. (34) y y y y n n y y n y y 7
In et al. (47) y y y y y n y y n y y 8 Other pathologies in adults
Gerhardt et al. (42) y y n y n n n n n y y 4
Gloeckl et al. (43) y y y y n n y n n y y 6
Gaßner et al. (41) y y n y n n n y n y y 5
Johnson et al. (49) y y n n n n n n n y y 3
Ahlborg et al. (27) y y n y n n n y y y y 6
Högler et al. (46) y y y y n n n n n y y 5 Other pathologies in children
Cheng et al. (37) y y n y n n n y y y y 6
Lee et al. (53) y y y y n n y y y y y 8
Ruck et al. (60) y y y y n n n n n y y 5
n, criterion not fulfilled; y, criterion fulfilled; 1, eligibility criteria were specified; 2, subjects were randomly allocated to groups or to a treatment order; 3, allocation was concealed; 4, the
groups were similar at baseline; 5, there was blinding of all subjects; 6, there was blinding of all therapists; 7, there was blinding of all assessors; 8, measures of at least one key outcome
were obtained from more than 85% of the subjects who were initially allocated to groups; 9, intention-to-treat analysis was performed on all subjects who received the treatment or
control condition as allocated; 10, the results of between-group statistical comparisons are reported for at least one key outcome; 11, the study provides both point measures and
measures of variability for at least one key outcome; total score, each satisfied item (except the first) contributes 1 point to the total score, yielding a PEDro scale score that can range
from 0 to 10. B, the level of evidence was B (randomized control trials that lacked double-blinding).
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FIGURE 2 | Comparison between WBV interventions and control groups in elderly subjects for the TUG test (A), 10MWT (B), 6MWT (C) and Tinetti gait score (D).
(mean PEDro score = 5.8 ± 1.0), so a strong level of evidence
supports the positive effect of WBV training on the TUG test.
For the 10MWT (Figure 2B), three studies were included in
meta-analysis and one study was excluded because it used a
different unit of measure (i.e., m/s instead of seconds in the
other studies) (69). Meta-analysis showed a significant decrease
in time on the 10MWT in WBV groups (SMD = −0.28; 95%
CI: −0.56, −0.01), with consistent results (I2 = 22%, p = 0.28).
The overall quality of the included studies was high (PEDro
score = 5.0 ± 0.0). Thus, a strong level of evidence supports
the positive effect of WBV training in improving gait speed
on the 10MWT.
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For the 6MWT (Figure 2C), two studies were included and
one was excluded due to a lack of data despite requests to
the authors (56). Meta-analysis showed no significant difference
between groups (SMD = 0.37; 95% CI: −0.03, 0.78), despite a
tendency toward an improvement in distance in WBV groups.
Results were consistent (I2 = 0%, p = 0.43) and the quality of
the included studies was high (PEDro score= 5.5± 0.7). Thus, a
strong level of evidence supports the lack of a beneficial effect of
WBV training for improving performance in the 6MWT.
For the Tinetti gait score (Figure 2D), three studies were
included in meta-analysis and three were excluded due to a lack
of data despite requests to the authors (9, 31, 36). Meta-analysis
showed no significant difference between groups (SMD = 0.04;
95% CI:−0.23, 0.31), with consistent results (I2 = 0%, p= 0.46).
The quality of the included studies was high (mean PEDro score
= 7.0± 1.0). Thus, a strong level of evidence supports the absence
of a positive effect of WBV training on the Tinetti gait score.
For biomechanical data recorded using the Locometrix
system (gait speed, stride frequency, stride length, stride
symmetry, stride regularity, cranio-caudal mechanic power,
antero-posterior mechanic power, medio-lateral mechanic
power, and counting speed), no comparison between groups
could be performed due to a lack of data despite requests to the
authors (31, 36). Both Beaudart et al. (31) and Buckinx et al. (36)
reported no significant inter-group difference for parameters
recorded by the Locometrix (p > 0.05).
Chronic COPD Patients
Four studies examined the effect of WBV on chronic COPD
patients (57, 61, 65, 71) with an average PEDro score of 5.2 ±
0.5. The sample size ranged from 28 to 62 participants with a
mean age of 66.2 ± 4.3 years. Three studies included both men
and women (61, 65, 71) and one included only male patients
(57). All of the studies specified the eligibility criteria and had
similar baselines. The training duration varied from 6 weeks
to 3 months. In two studies (57, 61), subjects performed three
WBV sessions per week, while patients had only two sessions
per week in the other two studies (65, 71). The frequency
and amplitude of the platform vibrations varied from 6 to
35Hz and 2 to 6mm, respectively. Intensity was progressively
increased in two studies (65, 71). Half of the studies used side-
alternating vibrations (65, 71) while the two other studies used
synchronous vibrations (57, 61). The number of vibration bouts
delivered per session varied from three to eight sets with a period
lasting between 30 s and 2min for each. Resting time was 60 s
to 2min. In two protocols (57, 71), the subjects maintained
a static position, while they performed dynamic exercises in
the other studies (61, 65). Only the 6MWT methodology was
used to test gait.
Comparisons to control groups (Figure 3A)
For the meta-analysis, two studies were included and two were
excluded because the control groups were intervention groups
with additional exercises not provided in the WBV group (i.e.,
not only WBV effects are measured) (61, 65). Meta-analysis
showed no significant difference between groups (SMD = 1.66;
95% CI: −0.17, 3.49) with heterogeneous results (I2 = 91%,
p = 0.0008). Thus, the level of evidence was conflicting for the
6MWT outcome in COPD.
For the excluded studies, Salhi et al. (61) showed that
there was no significant difference between WBV training and
conventional resistance training for improving 6MWT scores
(SMD=−0.24; 95% CI:−0.79, 0.31). Similar results were found
by Spielmanns et al. (65), where no significant difference was
shown between theWBV intervention and the calisthenics group
(SMD= 0.54; 95% CI:−0.23, 1.32).
Comparison to pre-intervention (Figure 3B)
A second meta-analysis was conducted to include the four
studies. Meta-analysis demonstrated a significant improvement
in the distance walked during the 6MWT after WBV treatment
(SMD = 0.92; 95% CI: 0.32, 1.51). Again, because there were
heterogeneous results (I2 = 66%, p = 0.03), the level of evidence
was conflicting for the 6MWT outcome.
Stroke Patients
Seven studies examined the effect of WBV on stroke patients
(28, 35, 38, 51, 54, 67, 72) with an average PEDro score of 7.2
± 1.7. The sample size ranged from 21 to 84 participants with
a mean age of 58.3 ± 4.5 years. All of the studies included both
men andwomen. All explained the eligibility criteria. Two studies
(35, 38, 51, 72) found significant differences between groups for
some outcomes at baseline. The training duration varied from
4 to 8 weeks. In four studies, subjects performed three sessions
per week (28, 51, 54, 72), while patients had five sessions per
week in two studies (38, 67), and two sessions per week in one
study (35). The frequency and amplitude of platform vibrations
varied from 20 to 40Hz and 0.44 to 5mm, respectively. The
intensity was progressively increased in two studies (51, 72).
Three studies used side-alternating vibrations (38, 67, 72), three
synchronous vibrations (35, 51, 54), while one did not mention
the type of vibrations (28). The number of vibration bouts
delivered per session varied from 2 to 135 sets with a period
lasting from 10 to 150 s each. Resting time was between 3 and 60 s.
In four protocols (28, 35, 38, 67), the subjects maintained a static
position, performed dynamic exercises in two studies (51, 72)
and both types of exercises in one study (54). The TUG test was
assessed in three studies (35, 38, 54), the 6MWT in three studies
(35, 51, 54) and the 10MWT in two (28, 51). Only one study
used a biomechanical methodology to assess gait function (72)
and one study used the Functional Ambulation Categories (FAC)
scale (67).
Comparisons to control groups (Figures 4A and 4C)
Two meta-analyses were conducted for the TUG test and
the 6MWT.
For the TUG test, two studies were included and one study
was excluded because the groups were statistically different
at baseline (35). Meta-analysis demonstrated no significant
difference between groups (SMD =−0.21; 95% CI:−0.55, 0.13),
with consistent results (I2 = 0%, p = 0.83). The quality of the
study was high (mean PEDro score = 8.0 ± 0.0). Thus, a strong
level of evidence supports the absence of effect of WBV training
on the TUG test in stroke patients.
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FIGURE 3 | Comparisons between WBV interventions and control groups in COPD for the 6MWT (A). Illustrates the change in the 6MWT following WBV intervention
compared to the pre-intervention status (B).
For the 6MWT, two studies were included and one study
was excluded because the groups were statistically different
at baseline (35). Meta-analysis demonstrated no significant
difference between the groups (SMD = −0.09; 95% CI: −0.37,
0.19), with consistent results (I2 = 0%, p = 0.70). The quality
of the study was high (mean PEDro score = 6.0 ± 2.8). Thus, a
strong level of evidence supports the absence of effect of WBV
training on the 6MWT test in stroke patients.
For biomechanical data, Choi et al. (72) demonstrated no
significant difference between groups for stride length (SMD =
0.50; 95% CI: −0.23, 1.23) and walking speed (SMD = 0.32; 95%
CI:−0.40, 1.04). Similarly, walking speed assessed by the 10MWT
(51) was not different between groups (SMD = 0.39; 95% CI:
−0.05, 0.83). Finally, the Functional Ambulation categories scale
(67) was not different between groups (SMD = 0.00; 95% CI:
−0.54, 0.54) after the interventions. All studies were of high
quality RCT (Perdro scores ≥ 5/10). Thus, the level of evidence
for each outcome was considered moderate.
Comparisons to pre-intervention (Figures 4B and 4D)
Two additional meta-analyses were conducted to include the two
studies excluded for group comparisons for the TUG test and the
6MWT outcomes.
For the TUG test, meta-analysis showed a tendency but no
significant improvement after the WBV treatment (SMD =
−0.29; 95% CI: −0.60, 0.01) with consistent results (I2 = 0%,
p = 0.89). The overall quality of the included studies was high
(mean PEDro score= 7.0± 2.6). Thus, a strong level of evidence
supports the absence of effect of WBV treatment on the TUG test
in stoke patients.
For the 6MWT, meta-analysis showed a significant
improvement after WBV treatment (SMD = −0.33; 95%
CI: 0.06, 0.59) with consistent results (I2 = 0%, p = 0.58). The
overall quality of the included studies was high (mean PEDro
score = 8.3 ± 0.5). Thus, a strong level of evidence supports the
positive effect of WBV treatment to improve the distance walked
during the 6MWT test in stroke patients.
Knee Osteoarthritis
Four studies examined the effect of WBV on patients suffering
from knee osteoarthritis (29, 33, 63, 68). The studies had an
average PEDro score of 6.5 ± 1.2. The sample size ranged from
21 to 49 subjects with a mean age of 65.1 ± 9.2 years. Two
studies included both men and women (33, 68), while two studies
did not mention the gender of the patients (29, 63). All of the
studies specified the eligibility criteria and had similar baselines.
The training duration ranged from 8 to 24 weeks. Three studies
had a frequency of three sessions per week (29, 33, 63) while the
other had five (68). The frequency and amplitude of the platform
vibrations varied from 25 to 40Hz and 2 to 6mm, respectively.
The intensity was progressively increased in all studies. Two
studies used synchronous vibrations (33, 63) while two did not
mention the type of vibrations of the devices (29, 68). The
number of vibration bouts delivered per session varied from six to
30 sets with a period lasting 20 to 70 s. Resting time was between
20 and 70 seconds. In three protocols (29, 33, 68), the subjects
maintained a static position, but performed static and dynamic
exercises in the other study (63). Three studies used the TUG test
(29, 33, 68), three used the 6MWT (29, 63, 68) and one combined
the 2MWT and the 50FWT with the TUG (33).
Comparisons to control groups
For the TUG test (Figure 5B), two studies were included and one
was excluded due to a lack of data (33). Meta-analysis showed no
significant difference between groups (SMD = −1.54; 95% CI:
−4.65, 1.56) with heterogeneous results (I2 = 97%, p < 0.00001).
Thus, the level of evidence was conflicting.
For the 6MWT (Figure 5A), meta-analysis showed a
significant difference in favor of the WBV group (SMD = 1.28;
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FIGURE 4 | Comparisons between WBV interventions and control groups in stroke patients for the 6MWT (A) and the TUG test (C). Illustrates the changes in the
6MWT (B) and the TUG test (D) following WBV intervention compared to the pre-intervention status.
95% CI: 0.57, 1.99), with consistent results (I2 = 64%, p = 0.06).
The quality of the studies was high (mean PEDro score = 6.6 ±
1.5). Thus, a strong level of evidence supports the positive effect
of addingWBV to improve the 6MWT in patients with knee OA.
Postmenopausal Women
Three studies examined the effect of WBV on postmenopausal
patients (48, 58, 66). These studies had an average PEDro score
of 4.6 ± 1.1. The sample size ranged from 27 to 52 participants
with a mean age of 65.8±8.4 years. All of the studies specified
eligibility and had similar baselines. The training durations
ranged from 4 weeks to 8 months. One study had a frequency
of five sessions per week (66), another of three sessions per week
(58), while the last one did not specify the number of sessions per
week (48). The frequency of the platform vibrations varied from
6 to 35Hz and the amplitude was indicated in only one study
(6mm). The intensity of the sessions was progressively increased
in two studies during training duration (58, 66). One study used
synchronous vibrations (66) and the other two studies did not
mention the type of vibrations (48, 58). The vibration bouts were
delivered from 30 to 60 s with two to six sets. Resting time was
60 s in two studies (58, 66) and was not indicated in the third
(48). In all protocols, the subjects maintained a static standing
position. Two studies used the TUG (48, 66) and one combined
it with a 10MWT (48). The third study measured walking speed
along a four-meter pathway (58). Meta-analysis could not be
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FIGURE 5 | Comparison between WBV interventions and control groups in patients with knee OA for the 6MWT (A) and the TUG test (B).
performed for the TUG test due to a lack of post-intervention
data in all three studies, despite requests to the authors. Two
studies reported significant improvement of the 10MWT after
WBV training (p < 0.05 and p = 0.006) (48, 58). Sucuoglu et al.
(66) showed a significant improvement of the TUG test post
treatment (p < 0.005), whereas Iwamoto et al. (48) found no
significant difference between groups (p > 0.05).
Multiples Sclerosis
Two studies examined the effect of WBV on patients with
multiple sclerosis (34, 39). The studies had an average PEDro
score of 6.0 ± 1.4. The sample size ranged from 25 to 34
participants with a mean age of 43.4 ± 6.3 years. Both studies
included both men and women, specified the eligibility criteria
and had similar baselines. The training duration was 10 and 20
weeks. In one study, patients underwent three sessions per week
(39), while in the other they performed an average of 2.5 sessions
per week (34). The frequency and amplitude of the platform
vibrations varied from 2 to 45Hz and 2 to 2.5mm, respectively.
The intensity was progressively increased in both studies. One
study used synchronous vibrations (34) while the other did not
mention the type of vibrations (39). The number of vibration
bouts delivered per session varied from 2 to 15 sets with a period
lasting 30 to 120 s. Resting time was between 30 and 120 s. In
one protocol (39), the subjects maintained a static position, while
they performed static and dynamic exercises in the other (34).
Both studies used the TUG test. One study combined it with the
10MWT and the 6MWT (39), while the other used the TUG with
the 2MWT and the 25-foot walk test (34).
Comparisons to control groups
In one study, no meta-analysis was conducted for between-group
comparisons because the groups were statistically different at
baseline for the TUG test and 2MWT (34).
Ebrahimi et al. (39) found no significant difference between
groups for the TUG test (SMD = −0.47; 95% CI: −1.20, 0.26).
However, they did observe significant improvement in the WBV
group for the 10MWT (SMD = −1.05; 95% CI: −1.82, −0.28)
and the 6MWT (SMD = 1.22; 95% CI: 0.43, 2.01). The level
of evidence was high (PEDro score = 5/10). Thus, the level of
evidence was considered moderate for each outcome.
Comparison to pre-intervention
Meta-analysis (Figure 6) showed no significant improvement in
the TUG test after WBV training (SMD = −0.11; 95% CI−0.64,
0.43) with consistent results (I2 = 0%, p = 0.71). The overall
quality of the included studies was high (mean PEDro score =
6.0 ± 1.4). Thus, there is a strong level of evidence to conclude
that WBV treatment had no impact on the TUG test in patients
with multiple sclerosis.
Other Pathologies in Adults
Six studies reported results on different pathologies in adult
patients(27, 41–43, 47, 49): incomplete cervical spinal injury
(47), pulmonary arterial hypertension (42), lung transplantation
(43), idiopathic Parkinson’s disease (41), total knee arthroplasty
(49) and cerebral palsy (27). The average PEDro score was 5.3
± 1.7. The sample size ranged from 14 to 83 subjects with
a mean age of 54.6 ± 14.1 years. All of the studies included
both men and women. All specified the eligibility criteria and
had similar baselines except for one study where patients were
statically different at baseline for certain outcomes (49). Training
duration varied from 4 to 8 weeks. In four studies, subjects
performed three WBV sessions per week (27, 41, 43, 49), while
in one study they had four sessions per week (42), and five
in another (47). The frequency and amplitude of the platform
vibrations varied from 6 to 40Hz and 2 to 20mm, respectively.
The frequency or amplitude of the vibrations was progressively
increased in four studies (27, 43, 47, 49). Two studies used
side-alternating vibrations (42, 43), one study used synchronous
vibrations (47) and the other three studies did not mention the
type of vibrations (27, 41, 49). The number of vibration bouts
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FIGURE 6 | Changes in the TUG test following WBV intervention compared to the pre-intervention status in patients with multiple sclerosis.
delivered per session varied from 1 to 18 sets with a period lasting
30 to 120 s. Resting time was between 15 and 240 s. In three
protocols (27, 41, 47), the subjects maintained a static position,
while they performed dynamic exercises in two others (42, 43)
and combined both in the last study (49). Four studies used the
TUG test (27, 41, 47, 49) and three used the 6MWT (27, 42,
43) (one study combined both). One study used biomechanical
analysis combined with the clinical TUG test (41). No meta-
analysis was conducted due to the heterogeneity of patients in
this subgroup.
Comparisons to control groups
In patients with incomplete cervical spinal injury, In et al. (47)
found no significant difference between the WBV group and
control group for the TUG test (SMD = −0.64; 95 CI: −1.40,
0.13) and the 10MWT (SMD=−0.23; 95% CI:−0.97, 0.52). The
quality of the study was high (PEDro score = 8/10). Thus, the
level of evidence was moderate.
In patients diagnosed with idiopathic Parkinson’s disease,
Gaßner et al. (41) observed no significant difference between the
WBV group and the placebo group for the TUG test (SMD =
−0.37; 95% CI: −1.34, 0.59), gait velocity (SMD = −0.21; 95%
CI: −1.17, 0.74) and step length (SMD = 0.14; 95% CI: −0.81,
1.09). The quality of the study was high (PEDro score = 5/10).
Thus, the level of evidence was moderate.
After total knee arthroplasty, Johnson et al. (49) reported no
significant difference for the TUG test between aWBV group and
a resistance training group (SMD=−0.59; 95% CI:−1.59, 0.42).
The quality of the study was low (PEDro score=3/10). Thus, the
level of evidence was limited.
In patients with cerebral palsy, Ahlborg et al. (27) found no
significant difference between a WBV group and a resistance
training group for the TUG test (SMD = 0.28; 95% CI: −0.77,
1.34). The quality of the study was high (PEDro score=6/10).
Thus, the level of evidence was moderate.
SMD could not be reported in the study of Gerhardt et al.
(42) and Gloeckl et al. (43) due to the lack of post-intervention
data despite a request to the authors. The authors of the first
study indicated that WBV was associated with a significant
improvement of the 6MWD vs. baseline of +38.6 ± 6.6m (p <
0.001) (42). The authors of the second study reported a significant
between-group difference of 28m (95% CI: 3, 54; p = 0.029) in
favor of WBV (73).
Comparisons to pre-intervention
Ahlborg et al. (27) reported no significant difference after WBV
(SMD = 0.14; 95% CI: −0.91, 1.19) in patients with cerebral
palsy, with a level of evidence considered moderate (PEDro score
= 6/10). Similarly, Johnson et al. (49) observed no significant
improvement of the TUG test after WBV (SMD = 1.02; 95%
CI: −0.04, 2.09) in patients with total knee arthroplasty, with a
limited level of evidence (PEDro score= 3/10).
Other Pathologies in Children
Four studies examined the effect of WBV in children(37, 46, 52,
60): two evaluated the effects of WBV in cerebral palsy (37, 60),
one in patients with osteogenesis imperfect (46) and one in
patients with spastic diplegia or quadriplegia forms of cerebral
palsy (52). The studies had an average PEDro score of 6.0 ± 1.4.
The sample size ranged from 16 to 30 participants with a mean
age of 8.7 ± 0.8 years. All of the studies included both boys and
girls, specified the eligibility criteria and had similar baselines.
The training duration varied between 8 and 24 weeks. One study
had a frequency of two sessions per week (46), one had three
sessions per week (52), one had five sessions per week (60), while
the number of sessions was not specified in the last study (37).
The frequency and amplitude of the platform vibrations varied
from 5 to 25Hz and 1 to 9mm, respectively. The frequency or
amplitude of the vibrations was progressively increased in three
studies (46, 52, 60). Two studies used synchronous vibrations
(37, 60) and the other two studies used side-alternating vibrations
(46, 52). The number of vibration bouts delivered per session
varied from three to six sets with periods lasting 3min each.
Resting time was also 3min. In two protocols (37, 52), the
subjects maintained a static position, while they performed
static and dynamic exercises in the other studies(46, 60). Two
studies used the 6MWT (37, 46), and one study combined it
with the TUG test (37). One study used biomechanical analysis
including gait speed, stride length and cycle time (52). One
study used the 10MWT (for gait speed) (60). Three studies
reported significant improvement in gait parameters following
WBV treatment (37, 52, 60), whereas one study reported that
the 6MWT remained unchanged (46). No meta-analysis was
conducted due to the heterogeneity of patients in this subgroup.
Additionally, data post interventions were not reported in three
studies (37, 46, 60).
Comparisons to control groups
In children with clinically mild to moderate osteogenesis
imperfecta, Högler et al. reported no significant difference
between groups for the 6MWT (p= 0.278) (46).
In children with cerebral palsy, Cheng et al. reported
a significant difference between the treatment and control
conditions for the 6MWT (p = 0.005) (37). Ruck et al. reported
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a significant improvement in the 10MWT in favor of WBV
(p= 0.03) (60).
Finally, in patients with either spastic diplegia or quadriplegia
forms of cerebral palsy, Lee and Chon found significant
improvement in favor of the WBV group for gait speed (SMD
= 1.41; 95% CI: 0.60, 2.22) and stride length (SMD = 0.91; 95%
CI: 0.15, 1.67) (52), with a level of evidence considered moderate
(PEDro score= 8/10).
DISCUSSION
The aim of this systematic review was to determine the changes in
gait outcomes after WBV training in healthy adults and various
patient categories. We found a strong level of evidence for a
positive effect of WBV training on the TUG test and the 10MWT
in the elderly. The same level of evidence was found in favor
of a significant improvement of the 6MWT in stroke patients
and patients with knee OA. In contrast, there is no change
in the 6MWT and the Tinetti gait score in the elderly, and
the TUG test was not improved in stroke or multiple sclerosis
patients. Conflicting results were found in COPD patients despite
significant improvements in the 6MWT. Other outcomes showed
a moderate or limited level of evidence, due to a lack of data or
because only one RCT was identified.
As mentioned in a prior review (20), the major obstacle
in conducting meta-analysis and establishing strong evidence
on the effects of WBV on gait is the heterogeneity in
study methodologies. Intervention regimes, settings, combined
interventions and control groups varied greatly. As in any
training protocol, numerous factors can affect the results of the
program (e.g., the duration of the intervention; the frequency or
volume of the sessions; the type, frequency and amplitude of the
vibrations and the exercises performed on the platform). Because
the studies used different protocols, a random-effects model was
used. In the presence of heterogeneity, a random-effects meta-
analysis weights the studies relatively more equally than a fixed-
effect analysis (25). Because control groups varied a great deal
in terms of interventions (i.e., exercises, physical therapy, sham,
no interventions etc.), intergroup comparisons were not always
possible, so we added within group comparisons (i.e., pre vs.
post WB) to estimate the effect of the treatment. Additionally,
some groups were statistically different at baseline for certain
outcomes (35, 40, 62), making between groups comparisons
impossible after intervention. The results of each patient category
are discussed below.
On the one hand, the results in the elderly showed significant
improvements in the TUG test and the 10MWT after WBV
intervention. These results are in favor of better dynamic stability
and gait performance as both outcomes are related to balance and
gait speed, respectively (45, 59).
However, the effect sizes were small (−0.18 and−0.28,
respectively) and the 6MWT was not significantly modified by
treatment despite a tendency toward improvement in favor of
WBV (SMD = 0.37; 95% CI: −0.03, 0.78). Our findings on
physical improvements partially corroborate earlier reports. In
a recent scoping review, Park et al. (74) concluded that WBV
training could be effective in increasing lean mass, muscular
strength and cardiovascular health (74). Positive changes in
body composition and fitness induced by WBV training may
explain the improvement in gait performance. After the age of
50, muscle mass decreases approximately 2% every year and
muscle strength decreases 15% every 10 years (75). These age-
related changes impact functional mobility, including gait speed,
static dynamic balance, and the risk of falling. As a resistance
training exercise, WBV appears efficient in attenuating the loss of
muscle mass and muscle strength. In order to combat the effects
of aging, it should be recommended that older adults perform
WBV 2 or 3 days per week, as suggested for resistance training
(76, 77). In addition, because both offer numerous benefits, these
interventions could be combined, depending on feasibility and
patient motivation. These recommendations are also valuable for
patients with reduced mobility and who need to improve their
autonomy at home, as only the TUG test and 10MWT (short-
distance walking tests) were improved but not the 6MWT (a
long-distance walking test).
On the other hand, the results support that gait performance
can be improved with no improvement in qualitative aspects
of the locomotion pattern. In fact, the quality of gait, assessed
by the Tinetti test, was not changed. The outcome is classically
divided in two parts. One assesses static balance, while the
second asses dynamic balance (78, 89). Because gait was the main
outcome of the present research, we did not include the total
score in meta-analysis. All 28 points are necessary to assess the
whole balance score, and thus, the risk of falling. Additionally,
the Tinetti total score has been recently demonstrated as being
related tomusclemass and strength (79). As previously discussed,
improvements in muscle mass, strength, and performance are
demonstrated after WBV training. Thus, changes in the Tinetti
total score can be expected and further investigation on this
outcome is warranted.
The results in stroke patients are more mitigated. On
the one hand, between-group comparisons showed that the
6MWT was not modified by WBV training. However, two
studies had to be excluded from this analysis and a second
analysis was performed to include them in a pre vs. post
comparison. This time, the results showed a significant increase
in distance after a WBV intervention. On the other hand,
no significant changes were found for the TUG test in both
comparisons, despite a tendency toward an improvement.
The 6MWT is commonly used to assess aspects of walking
performance in stroke survivor studies (80). It evaluates the
global responses of all the systems involved during exercise,
including the pulmonary and cardiovascular systems, systemic
circulation, peripheral circulation, blood, neuromuscular units,
and muscle metabolism (90). The results concerning the
6MWT confirm the findings discussed previously in favor of
functional improvements in elderly and disease populations
(74). Conflicting results emerged from the TUG test. Balance,
assessed by the TUG test, appeared less modified by the WBV
treatment in the treatment of neuropathologic subjects than in
the elderly population. This was confirmed by the poor results in
multiple sclerosis patients included in meta-analysis for the TUG
outcome (34, 39).
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Conflicting results were also found for the 6MWT in
COPD patients. The pooled studies demonstrated a significant
improvement of the distance walked but with inconsistent
results. The size of the overall effect was large (SMD = 0.92;
95% CI:0.32, 1.51) and seems to corroborate the functional
improvement observed after WBV. However, the results must be
taken with caution because of their heterogeneity and the small
sample of high quality studies revealed by the present review (i.e.,
four studies) (57, 61, 65, 71). Heterogeneity was found in both
intergroup comparison and comparison with pre intervention,
and was difficult to explain as the studies had similar populations
(i.e., older adults with COPD) and settings (i.e., frequency and
amplitude of the vibrations).
In patients with knee OA, a strong level of evidence supports
the beneficial effect of WBV training in improving the 6MWT,
with a large effect size (SMD=1.28; 95% CI: 0.57, 1.99).
Interestingly,Wang et al. showed that addingWBV to quadriceps
resistance training was more efficient that resistance training
alone (SMD = 1.68; 95% CI: 1.22, 2.14) (68). A recent review
showed that, in patients with knee OA, a resistance training
program is effective for improving knee extensor strength but
has limited effect on pain and disability if the gains are <30%
(81). WBV interventions combined with strength training may
help achieve this gain necessary for beneficial effects on pain and
functional performance. Again, for the TUG test, Wang et al.
(68) demonstrated the value of combining WBV and resistance
training to improve gait performance (SMD = −3.11; 95% CI:
−3.71, −2.52). However, because of the absence of effect in
the second study (29), the level of evidence was conflicting.
Heterogeneity might be explained by the two major differences
between the studies, which were the addition of quadriceps
resistance training and the doubled duration of the training (i.e.,
24 vs. 12 weeks) in Wang et al. (68).
Although some significant gait improvements after WBV
were reported, it is important to stress that significant
statistical changes are not always linked to significant clinical
improvements for patients. For example, in elderly patients,
Bogaerts et al. (32) reported a significant improvement of the
time required to perform the TUG test after WBV intervention.
While the time was decreased from 13.1 s to 11.19 s (SMD =
−0.71; 95%CI: −1.10, −0.32) with an effect size considered
moderate, this differencemay not correspond tomajor changes in
the patients’ daily activities. Thus, the benefit of a non-functional
intervention such as WBV should always be questioned with
regard to each patient’s goals.
However, WBV appears to be a time-efficient and easy-to-
use intervention that is both relatively inexpensive and safe
for patients with balance deficits. Vibration plates are readily
available at all rehabilitation hospitals/centers.Moreover, it might
be interesting to complete certain conventional rehabilitation
programs like resistance or balance training with WBV training
that may offer the same results. For example, for COPD patients,
it has been found that both the WBV and resistance training
groups significantly improved in the 6MWT (61, 65, 71) with
no significant difference between the groups. Additionally, no
control group including any form of training was significantly
superior to WBV training in improving gait.
Most of the studies included in this review (27/43 articles)
reported a drop-out rate of <15% during their interventions.
Considering that most of the subjects were patients with diseases
or physical disorders, it is logical to assume that they would have
stopped treatment had they experienced any harmful or adverse
side effect. This might support the hypothesis that the patients
tolerated vibration training well. Moreover, WBV training has
been reported to be appreciated and considered a safe training
method. The fact that participants could perform either dynamic
or static exercises while holding a bar increases safety and would
be beneficial for the weakest populations such as elderly persons
with balance impairments.
The vibration type may impact the training response. side-
alternating WBV has been shown to increase heart rate higher
than synchronous vibrations in young sedentary women during
20-min sessions (82). This illustrates the potential of WBV to
improve fitness capacity, particularly in less active populations.
Additionally, higher electromyography of knee extensor and
plantar flexor activities were observed with a side-alternating
vibration platform compared to synchronous vibrations (83).
Although these results are in favor of side-alternating vibrations,
our review showed heterogeneous results regarding the vibration
type when it was mentioned. Significant improvements in gait
parameters were found in 13 studies that used synchronous
vibrations (9, 30, 33, 37, 40, 47, 51, 57, 59–61, 63, 66) and in seven
studies that used side-alternating vibrations (38, 42, 43, 48, 52,
65, 72). Again, because of the lack of consistency in the protocols
and results, it is difficult to reach a consensus on specific WBV
training to improve human locomotion.
We chose to select only studies on long-term effects because
they are better correlated to conventional physiotherapies that
often last many weeks. Moreover, long-term effects have been
studied more than short-term or even immediate effects. We
found that a wide range of protocols lasted 6 weeks or more and
a few lasted 4 weeks. However, we can add that only a few RCT
focused on the acute effects of WBV training on gait parameters
(84–86). In the future, it might be interesting to compare different
WBV protocols (i.e., with different WBV frequencies) in order to
evaluate the effect of high vs. lowWBV frequency on balance and
gait within a single session.
Finally, most studies used clinical assessments instead of
biomechanical analysis (41, 52, 72). Since it might be a
more objective measure, future studies should integrate this
kind of outcome more often in order to compare it with
functional assessments.
LIMITATIONS OF THE STUDY
Results of meta-analysis must be taken with caution as some
studies could not be included in the comparisons due to a lack
of complete data, notably for the TUG test and Tinetti gait score
in the elderly, despite requests to the authors.
The Cochrane Qualitative and Implementation
Methods Group recommends the application of Grades of
Recommendation, Assessment, Development, and Evaluation
(GRADE) in the Evidence from Qualitative Reviews to assess
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confidence in qualitative synthesized findings (87). However, the
GRADE necessitates assessing the risk of publication bias with a
funnel plot, determining its asymmetry, which can be performed
with at least ten studies (88). Because most of the statistical
analyses were conducted on few RCT, we decided to implement
other guidelines described by a Cochrane collaboration group to
assess the level of evidence (26). Because this method includes
fewer criteria, our confidence in the results must be taken
with caution.
CONCLUSION
While WBV training appears to be a useful and relatively
successful tool in improving gait and walking abilities, it remains
unclear whether the treatment could be generalized to all
patients. Some populations have been studied more than others
with varying degrees of consistency. In the elderly, there is
a strong level of evidence that WBV can improve mobility
by improving the TUG test, and gait speed by improving the
10MWT. The results also showed significant improvements to
functional performance in stroke patients and patients with
knee OA by improving the 6MWT. However, the treatment
was inefficient in changing the TUG test in stroke and multiple
sclerosis patients, and conflicting results were obtained for the
6MWT in COPD. Finally, other outcomes were studied less and
the level of evidence was moderate or even limited depending of
the quality of the study. The transferability of this kind of training
to daily activities remains unclear and the use of vibration
training to replace functional rehabilitation must always be
questioned. Further research is needed to explore the possibility
of finding a standardized protocol targeting gait ability in a wide
range of populations.
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